Drug recall D-0453-2021
Product
Spiriva HandiHaler (tiotropium bromide inhalation powder) For Oral Inhalation Only 18 mcg (as tiotropium) per capsule Rx only NDC 0597-0075-41 Manufactured by: Boehringer Ingelheim (BI) Pharma GmbH & Co. KG Ingelheim, Germany Marketed by: Boehringer Ingelheim Pharmaceuticals, Inc. Ridgefield, CT 06877 USA and Pfizer, Inc. New York, NY 10017 USA
Reason for recall
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Lots and codes
5098
Recall details
- Recalling firm
- Cardinal Health Inc., Dublin, OH
- Quantity
- 2611 inhalers
- Distribution
- FL, GA, SC
- Type
- Voluntary: Firm initiated
- Recall initiated
- March 15, 2021
- Terminated
- June 17, 2024
Related products
- Spiriva – drug information
- NDC 0597-0075 Spiriva HandiHaler · Tiotropium Bromide Monohydrate 18 ug/1 · Boehringer Ingelheim Pharmaceuticals, Inc.